Richard Faint

Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance

Shouming Wang, Adrian Folkes, Irina Chuckowree et al. · Journal of Medicinal Chemistry · 2004 · 79 citations · Full text

Drug Target, Multidrug Resistance, Selective Inhibitors +17

Evaluation of a Low Molecular Weight Modulator of Human Plasminogen Activator Inhibitor-1 Activity

Peter Charlton, Richard Faint, Fiona Bent et al. · Thrombosis and Haemostasis · 1996 · 78 citations

Immunology, Clot Lysis, Pharmacotherapy +20

Inhibition of Plasminogen Activator Inhibitor-1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp.

Justin S. Bryans, Peter Charlton, Inês Chicarelli-Robinson et al. · The Journal of Antibiotics · 1996 · 61 citations · Full text

Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1

Adrian Folkes, Michael B. Roe, Sukhjit Sohal et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 58 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Pharmaceutical Science +12

Polymerization of Plasminogen Activator Inhibitor-1

Aiwu Zhou, Richard Faint, Peter Charlton et al. · Journal of Biological Chemistry · 2001 · 58 citations · Full text